170 related articles for article (PubMed ID: 29296171)
1. MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma.
Ambrosio MR; Mundo L; Gazaneo S; Picciolini M; Vara PS; Sayed S; Ginori A; Lo Bello G; Del Porro L; Navari M; Ascani S; Yonis A; Leoncini L; Piccaluga PP; Lazzi S
Oncotarget; 2017 Dec; 8(64):107356-107373. PubMed ID: 29296171
[TBL] [Abstract][Full Text] [Related]
2. Plasmablastic lymphoma: An update.
Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
[TBL] [Abstract][Full Text] [Related]
3. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphomas show restricted EBV latency profile and
Ramburan A; Kriel R; Govender D
Leuk Lymphoma; 2022 Feb; 63(2):370-376. PubMed ID: 34612761
[TBL] [Abstract][Full Text] [Related]
5. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
[TBL] [Abstract][Full Text] [Related]
6. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.
Zhou T; Cheng J; Karrs J; Davies-Hill T; Pack SD; Xi L; Tyagi M; Kim J; Jaffe ES; Raffeld M; Pittaluga S
Am J Surg Pathol; 2022 Oct; 46(10):1364-1379. PubMed ID: 35650679
[TBL] [Abstract][Full Text] [Related]
8. EBV infection determines the immune hallmarks of plasmablastic lymphoma.
Gravelle P; Péricart S; Tosolini M; Fabiani B; Coppo P; Amara N; Traverse-Gléhen A; Van Acker N; Brousset P; Fournie JJ; Laurent C
Oncoimmunology; 2018; 7(10):e1486950. PubMed ID: 30288350
[TBL] [Abstract][Full Text] [Related]
9. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
[TBL] [Abstract][Full Text] [Related]
10. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder.
Liu F; Asano N; Tatematsu A; Oyama T; Kitamura K; Suzuki K; Yamamoto K; Sakamoto N; Taniwaki M; Kinoshita T; Nakamura S
Histopathology; 2012 Dec; 61(6):1183-97. PubMed ID: 22958176
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
13. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
Boy SC; van Heerden MB; Raubenheimer EJ; van Heerden WF
J Oral Pathol Med; 2010 May; 39(5):435-9. PubMed ID: 20537055
[TBL] [Abstract][Full Text] [Related]
14. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
15. Extraoral plasmablastic lymphoma with intravascular component and MYC translocation.
Chapman-Fredricks J; Montague N; Akunyili I; Ikpatt O
Ann Diagn Pathol; 2012 Jan; 16(1):48-53. PubMed ID: 21239197
[TBL] [Abstract][Full Text] [Related]
16. Exploration and analysis of differentially expressed genes in Epstein-Barr virus negative and positive plasmablastic lymphoma.
Liang Y; Wang H; Luo B
Clin Transl Oncol; 2023 Oct; 25(10):2884-2891. PubMed ID: 36991219
[TBL] [Abstract][Full Text] [Related]
17. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
Valera A; Balagué O; Colomo L; Martínez A; Delabie J; Taddesse-Heath L; Jaffe ES; Campo E
Am J Surg Pathol; 2010 Nov; 34(11):1686-94. PubMed ID: 20962620
[TBL] [Abstract][Full Text] [Related]
18. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
19. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
Front Microbiol; 2014; 5():728. PubMed ID: 25566237
[TBL] [Abstract][Full Text] [Related]
20. Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.
Martinez D; Valera A; Perez NS; Sua Villegas LF; Gonzalez-Farre B; Sole C; Gine E; Lopez-Guillermo A; Roue G; Martinez S; Sant F; Warzocha K; Robak T; Czader M; Villamor N; Colomo L; Campo E; Martinez A
Am J Surg Pathol; 2013 Feb; 37(2):272-81. PubMed ID: 23282972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
